| Dr Melissa Lane Thompson, MD | |
|
68-1602 Laie St, Waikoloa, HI 96738 | |
| (281) 744-2374 | |
| Not Available |
| Full Name | Dr Melissa Lane Thompson |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 68-1602 Laie St, Waikoloa, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366430472 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | J0312 (Texas) | Primary |
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
One day a person experiences deep stress caused by a sudden happening (a traffic accident, a natural catastrophe, an episode of violence). Later on this person could develop a serious neuropsychiatric disorder that may last for years, post-traumatic stress disorder (PTSD).
A research team led by scientists from Brigham and Women's Hospital has developed a novel technology platform that enables the continuous and automated monitoring of so-called "organs-on-chips" - tiny devices that incorporate living cells to mimic the biology of bona fide human organs.
The Australian Government has introduced a new Medicare funded health check for Indigenous Australians to help prevent and treat chronic illness.
› Verified 4 days ago
| Entity Name | Northstar Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
One day a person experiences deep stress caused by a sudden happening (a traffic accident, a natural catastrophe, an episode of violence). Later on this person could develop a serious neuropsychiatric disorder that may last for years, post-traumatic stress disorder (PTSD).
A research team led by scientists from Brigham and Women's Hospital has developed a novel technology platform that enables the continuous and automated monitoring of so-called "organs-on-chips" - tiny devices that incorporate living cells to mimic the biology of bona fide human organs.
The Australian Government has introduced a new Medicare funded health check for Indigenous Australians to help prevent and treat chronic illness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Lane Thompson, MD Po Box 2295, Asheville, NC 28802-2295 Ph: (828) 398-5244 | Dr Melissa Lane Thompson, MD 68-1602 Laie St, Waikoloa, HI 96738 Ph: (281) 744-2374 |
News Archive
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
One day a person experiences deep stress caused by a sudden happening (a traffic accident, a natural catastrophe, an episode of violence). Later on this person could develop a serious neuropsychiatric disorder that may last for years, post-traumatic stress disorder (PTSD).
A research team led by scientists from Brigham and Women's Hospital has developed a novel technology platform that enables the continuous and automated monitoring of so-called "organs-on-chips" - tiny devices that incorporate living cells to mimic the biology of bona fide human organs.
The Australian Government has introduced a new Medicare funded health check for Indigenous Australians to help prevent and treat chronic illness.
› Verified 4 days ago
Dr. Michael Hart Plumer, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 68-1866 West Kaupapa Place, Waikoloa, HI 96738 Phone: 808-883-8846 |